Grand Pharmaceutical Group Limited — Earnings Release 2000

Sep 20, 2000

Listed Company Information

CHINA APOLLO<0512> - Results Announcement China Apollo Holdings Limited announced on 20/9/2000: (stock code: 512) Year end date: 31/12/2000 Currency: HKD (Unaudited) (Unaudited) Last Current Corresponding Period Period from 1/1/2000 from 1/1/1999 to 30/6/2000 to 30/6/1999 ('000) ('000) Turnover : 89,613 81,026 Profit/(Loss) from Operations : (63,683) (13,575) Finance Income, net : 717 1,386 Share of Profit/(Loss) of Associates : (2,723) (845) Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : (64,660) (13,222) % Change over Last Period : N/A EPS/(LPS)-Basic : (7.93 cents) (1.62 cents) -Diluted : N/A N/A Extraordinary (ETD) Gain/(Loss) : Nil Nil Profit/(Loss) after ETD Items : (64,660) (13,222) Interim Dividend per Share : Nil Nil (Specify if with other options) : Nil Nil B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for Current Period : N/A B/C Dates for Other Distribution : N/A Remarks: (1) Loss per share The calculation of loss per share for the six months ended 30th June, 2000 was based on the consolidated loss attributable to shareholders of approximately HK$64,660,000 (1999 - loss of HK$13,222,000) and the 815,100,000 shares (1999 - 815,100,000 shares) in issue during the period. Diluted loss per share for 2000 and 1999 are not shown as there was no dilution effect on the potential ordinary shares arising from the exercise of the outstanding share options because the exercise prices of the share options were greater than the average market prices. (2) Comparative figures Since the Group has adopted the revised Statement of Standard Accounting Practice ("SSAP") no. 1 (Presentation of Financial Statements), certain comparative figures in 1999 have been reclassified to conform to the current period's presentation.